// App-Quantinova.ai

211 : Edoxaban For Long-Term Treatment Of Venous Thromboembolism In Cancer Patients

Researchers

Presenter

  • Gary E. Raskob

Principal Investigators

  • Harry Buller

  • Pantep Angchaisuksiri

  • Doyeun Oh

  • Zoltan Boda

  • Roger Lyons

  • Jeffrey I. Weitz

  • George Zhang

  • Hans J Lanz

  • Michele Mercuri

Medical Centers

  • Institute of Internal Medicine, Center of Thrombosis and Haemostasis, University of Debrecen Medical and Health Science Center, Debrecen, Hungary

  • McMaster University, Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada

  • College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK

  • Pulmonary Medicine, Academic Medical Centre, Amsterdam, Netherlands

  • Cancer Care Centers of South Texas/US Oncology, San Antonio, TX

  • Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Locations

  • Canada

  • Netherlands

  • United States

  • Thailand

  • Hungary

Companies

  • Daiichi Sankyo Compa

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Solid malignancies

Biomarkers

  • Creatinine

Drug/Treatment

  • Edoxaban

  • Warfarin

  • Heparin

  • Lansoprazole

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved